Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.490
+0.020 (1.36%)
At close: Apr 10, 2026, 4:00 PM EDT
1.520
+0.030 (2.01%)
After-hours: Apr 10, 2026, 7:32 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $396.55 million as of April 10, 2026. Its market cap has decreased by -8.58% in one year.
Market Cap
396.55M
Enterprise Value
437.43M
1-Year Change
-8.58%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $396.55M, a decrease of -59.10%. That is a compound annual growth rate of -10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 396.55M | -25.13% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 411.57M |
| YD Bio | 405.04M |
| Ginkgo Bioworks Holdings | 400.47M |
| Enanta Pharmaceuticals | 399.60M |
| Neumora Therapeutics | 396.85M |
| Nautilus Biotechnology | 396.15M |
| Rocket Pharmaceuticals | 392.84M |
| PureTech Health | 391.19M |